Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Revolution Medicines Inc (RVMD)

Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,217,608
  • Shares Outstanding, K 198,173
  • Annual Sales, $ 0 K
  • Annual Income, $ -600,090 K
  • EBIT $ -1,037 M
  • EBITDA $ -1,070 M
  • 60-Month Beta 1.01
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 11.96

Options Overview Details

View History
  • Implied Volatility 77.15% (+7.89%)
  • Historical Volatility 59.12%
  • IV Percentile 97%
  • IV Rank 92.49%
  • IV High 80.37% on 04/08/25
  • IV Low 37.46% on 09/18/25
  • Expected Move (DTE 20) 10.23 (10.02%)
  • Put/Call Vol Ratio 3.13
  • Today's Volume 4,246
  • Volume Avg (30-Day) 6,313
  • Put/Call OI Ratio 0.92
  • Today's Open Interest 122,424
  • Open Int (30-Day) 137,664
  • Expected Range 91.79 to 112.25

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -1.77
  • Number of Estimates 10
  • High Estimate -1.50
  • Low Estimate -1.92
  • Prior Year -1.13
  • Growth Rate Est. (year over year) -56.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
93.02 +9.68%
on 02/04/26
107.45 -5.05%
on 02/25/26
+2.20 (+2.20%)
since 01/27/26
3-Month
73.00 +39.75%
on 12/16/25
124.49 -18.05%
on 01/16/26
+24.44 (+31.50%)
since 11/26/25
52-Week
29.17 +249.74%
on 04/07/25
124.49 -18.05%
on 01/16/26
+62.94 (+161.05%)
since 02/27/25

Most Recent Stories

More News
Revolution Medicines Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress

On track for readout of RASolute 302, a Phase 3 trial of daraxonrasib in second line metastatic PDAC, in first half of 2026 Continues to advance broad late-stage pipeline, with five ongoing Phase 3 trials...

RVMD : 102.02 (-0.13%)
Revolution Medicines to Participate in TD Cowen 46th Annual Health Care Conference

REDWOOD CITY, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted...

RVMD : 102.02 (-0.13%)
Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2025 After Market Close on February 25, 2026

REDWOOD CITY, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted...

RVMD : 102.02 (-0.13%)
Revolution Medicines to Participate in Guggenheim Securities Emerging Outlook: Biotech Summit 2026

REDWOOD CITY, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted...

RVMD : 102.02 (-0.13%)
Revolution Medicines Doses First Patient in Clinical Trial Evaluating RMC-5127, a RAS(ON) G12V-Selective Inhibitor

REDWOOD CITY, Calif., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced...

RVMD : 102.02 (-0.13%)
Stock Index Futures Gain on Tech Boost, FOMC Meeting and Earnings in Focus

March S&P 500 E-Mini futures (ESH26) are up +0.26%, and March Nasdaq 100 E-Mini futures (NQH26) are up +0.60% this morning, buoyed by gains in technology stocks, while investors await the start of the...

CVS : 79.90 (+2.42%)
AAPL : 264.18 (-3.21%)
ANET : 133.50 (+2.50%)
TXN : 212.11 (-0.24%)
UNH : 293.27 (+2.31%)
CRWV : 79.56 (-18.51%)
UNP : 264.98 (+0.34%)
STX : 407.84 (-0.45%)
RTX : 202.62 (+2.52%)
NQH26 : 25,004.75s (-0.30%)
PUM.D.DX : 23.930 (-3.55%)
AMD : 200.21 (-1.70%)
Stocks Close Higher Ahead of Heavy Earnings Week and FOMC Meeting

The S&P 500 Index ($SPX ) (SPY ) on Monday rose +0.63%, the Dow Jones Industrials Index ($DOWI ) (DIA ) rose +0.68%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.59%. March E-mini S&P futures (ESH26...

AAPL : 264.18 (-3.21%)
CSCO : 79.46 (+1.74%)
HL : 24.91 (+1.51%)
CDE : 27.15 (+2.22%)
$IUXX : 24,960.04 (-0.30%)
ZNM26 : 113-260s (+0.40%)
CRWV : 79.56 (-18.51%)
CRML : 10.15 (-6.71%)
TSLA : 402.51 (-1.49%)
ESH26 : 6,889.00s (-0.45%)
CTSH : 64.43 (-0.83%)
$DOWI : 48,977.92 (-1.05%)
Stocks See Support Ahead of Heavy Earnings Week and FOMC Meeting

The S&P 500 Index ($SPX ) (SPY ) today is up +0.51%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.26%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.57%. March E-mini S&P futures (ESH26...

GOOGL : 311.76 (+1.42%)
AAPL : 264.18 (-3.21%)
CSCO : 79.46 (+1.74%)
HL : 24.91 (+1.51%)
CDE : 27.15 (+2.22%)
$IUXX : 24,960.04 (-0.30%)
ZNM26 : 113-260s (+0.40%)
MSFT : 392.74 (-2.24%)
CRWV : 79.56 (-18.51%)
CRML : 10.15 (-6.71%)
TSLA : 402.51 (-1.49%)
ESH26 : 6,889.00s (-0.45%)
Stocks See Support Ahead of Heavy Earnings Week and FOMC Meeting

The S&P 500 Index ($SPX ) (SPY ) today is up +0.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.33%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.07%. March E-mini S&P futures (ESH26...

META : 648.18 (-1.34%)
AAPL : 264.18 (-3.21%)
MP : 58.87 (-1.88%)
CSCO : 79.46 (+1.74%)
HL : 24.91 (+1.51%)
CDE : 27.15 (+2.22%)
$SPX : 6,878.88 (-0.43%)
USAR : 18.90 (-6.11%)
$IUXX : 24,960.04 (-0.30%)
NQH26 : 25,004.75s (-0.30%)
QQQ : 607.29 (-0.32%)
ZNM26 : 113-260s (+0.40%)
Stocks Set for Muted Open After Trump’s Tariff Threats, Big Tech Earnings and Fed Meeting in Focus

March S&P 500 E-Mini futures (ESH26) are down -0.05%, and March Nasdaq 100 E-Mini futures (NQH26) are down -0.14% this morning, pointing to a muted open on Wall Street as President Trump’s tariff threats...

AAPL : 264.18 (-3.21%)
VZ : 50.14 (+2.56%)
CVX : 186.76 (+1.41%)
TXN : 212.11 (-0.24%)
UNH : 293.27 (+2.31%)
MSFT : 392.74 (-2.24%)
TSLA : 402.51 (-1.49%)
MA : 517.21 (+0.47%)
T : 28.01 (+2.00%)
IBM : 240.21 (-0.74%)
V : 320.14 (+1.09%)
RTX : 202.62 (+2.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Revolution Medicines Inc. is a clinical-stage oncology company. It is focused on developing targeted therapies to inhibit elusive frontier targets within notorious cancer pathways. Revolution Medicines Inc. is based in CA, United States.

See More

Key Turning Points

3rd Resistance Point 107.85
2nd Resistance Point 106.08
1st Resistance Point 104.05
Last Price 102.02
1st Support Level 100.25
2nd Support Level 98.49
3rd Support Level 96.46

See More

52-Week High 124.49
Last Price 102.02
Fibonacci 61.8% 88.08
Fibonacci 50% 76.83
Fibonacci 38.2% 65.58
52-Week Low 29.17

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar